Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Receivables (2016 - 2025)

Sanara MedTech's Receivables history spans 15 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Receivables rose 950.58% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $12.0 million, up 950.58%, while the annual FY2025 figure was $12.0 million, 950.58% up from the prior year.
  • Receivables reached $12.0 million in Q4 2025 per SMTI's latest filing, down from $12.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $12.1 million in Q3 2025 to a low of $23002.0 in Q1 2024.
  • Average Receivables over 5 years is $4.9 million, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Receivables: surged 4375.46% in 2023, then crashed 99.65% in 2024.
  • A 5-year view of Receivables shows it stood at $2.9 million in 2021, then soared by 134.81% to $6.9 million in 2022, then increased by 23.44% to $8.5 million in 2023, then tumbled by 86.6% to $1.1 million in 2024, then skyrocketed by 950.58% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Receivables are $12.0 million (Q4 2025), $12.1 million (Q3 2025), and $12.0 million (Q2 2025).